Phase 2 Trial of Neoadjuvant Camrelizumab Plus Chemotherapy or Apatinib for Resectable or Potentially Resectable NSCLC
JOURNAL OF THORACIC ONCOLOGY(2023)
关键词
Neoadjuvant immunotherapy,Non-small-cell lung cancer,Potentially resectable disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要